GlaxoSmithKline (GSK)
42.66
-0.11 -0.26%
NYSE
Jul 21, 20:00
Delayed 2m
USD
View All Key Stats
GSK Key Stats
| Income Statement | |
| Revenue (TTM) | 37.86B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.8317 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 2.051B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 65.97% |
| Profit Margin (Quarterly) | 14.17% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 4.67% |
| Price and Valuation | |
| Market Cap | 104.90B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 2.766 |
| PE Ratio (TTM) | 51.29 |
| Price to Book Value | 49.05 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 10.70 |
| Free Cash Flow (Quarterly) | 901.66M |
| Return on Equity (TTM) | 120.6% |
View All GSK News
GSK News
-
WireHeadlineTime (ET)
-
Yahoo07/21 17:01
-
MT Newswires07/21 16:17
-
SA Breaking News07/21 12:00
-
SA Breaking News07/21 11:47
-
MT Newswires07/21 10:16
-
MT Newswires07/21 09:30
-
Business Wire07/21 09:00
-
MT Newswires07/21 07:21
-
Yahoo07/20 18:19
-
Yahoo07/20 16:12
View All Events
GSK Events
| Date | Type | Description |
|---|---|---|
| 10/25/2017 | Earnings | GlaxoSmithKline PLC Third Quarter Earnings Results in 2017 |
| 07/26/2017 | Earnings | GlaxoSmithKline PLC Second Quarter Earnings Results in 2017 |
| 05/10/2017 | Dividends | Amount: 0.4882, Declared Date: Apr 26 2017, Pay Date: Jul 13 2017 |
| 05/04/2017 | Misc | GlaxoSmithKline PLC Annual General Meeting in 2016 |
| 04/26/2017 | Earnings | GlaxoSmithKline PLC First Quarter Earnings Results in 2017 |
| 03/14/2017 | Misc | GlaxoSmithKline PLC Annual Report in 2016 |
| 02/22/2017 | Dividends | Amount: 0.5758, Declared Date: Feb 08 2017, Pay Date: Apr 16 2017 |
| 02/08/2017 | Earnings | GlaxoSmithKline PLC Fourth Quarter Earnings Results in 2016 |
| 11/02/2016 | Dividends | Amount: 0.4621, Declared Date: Oct 31 2016, Pay Date: Jan 12 2017 |
| 10/26/2016 | Earnings | GlaxoSmithKline PLC Third Quarter Earnings Results in 2016 |
GSK Fundamentals
Income Statement View Statement
GSK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
GSK One Page Reports
- One Page Report Download
GSK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 42.66 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.gsk.com
- Investor Relations URL: http://www.gsk.com/en-gb/investors/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Next Earnings Release: Jul. 26, 2017
- Last Earnings Release: Apr. 26, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: May. 10, 2017
- Description: GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.
GSK Comparables
EditGSK Excel Add-In Codes
- Name: =YCI("GSK","name")
- Description: =YCI("GSK","description")
- Sector: =YCI("GSK","sector")
- Industry: =YCI("GSK","industry")
- Est. Current Fiscal Year End: =YCI("GSK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other GSK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GSK Tweets Stocktwits
Advertisement
